PUK10 Cost-Effectiveness Analysis of Solifenacin Versus Oxybutynin Immediate-Release in the Treatment of Patients With Overactive Bladder in the United Kingdom

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.545
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search